Colon Cancer: Open Trials


ABCSG C09/ASAMET

Randomized, phase II, double-blind, placebo-controlled, multicenter, 2x2 factorial design biomarker tertiary prevention trial of low-dose aspirin and metformin in stage I-III colorectal cancer patients.